Filing Details

Accession Number:
0001549084-22-000035
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-17 20:22:22
Reporting Period:
2021-06-10
Accepted Time:
2022-06-17 20:22:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1549084 Ekso Bionics Holdings Inc. EKSO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201619 Steven Sherman C/O Ekso Bionics Holdings, Inc.
1414 Harbour Way S, Ste. 1201
Richmond CA 94804
Ceo & Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-10 18,265 $0.00 655,673 No 4 A Direct
Common Stock Disposition 2022-06-15 6,911 $1.90 648,762 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
  2. This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders.
  3. Represents shares sold by the Reporting Person on June 15, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the Reporting Person's RSUs.
  4. The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.88 to $1.94, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.